Quest Diagnostics Incorporated
0KSX.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$25.5B
Close$
$173.60
26.7% downside
Current Fair Value
26.7% downsideOvervalued by 26.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $25.50 Billion |
|---|---|
| Enterprise Value | $31.26 Billion |
| Dividend Yield | $3.38 (1.46%) |
| Earnings per Share | $8.9 |
| Beta | 0.61 |
| Outstanding Shares | 111,000,000 |
Return
| Return on Equity | 14.13% |
|---|---|
| Return on Assets | 6.27% |
| Return on Invested Capital | 10.83% |
Valuation & Multiples
| P/E Ratio | 24.21 |
|---|---|
| PEG | 174.44 |
| Price to Sales | 2.28 |
| Price to Book Ratio | 3.38 |
| Enterprise Value to Revenue | 2.7 |
| Enterprise Value to EBIT | 19.05 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.85 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
$2.82
Average shareholder expectationRevenue Estimate
$2.97 B
Average shareholder expectationNext Earnings Call
Expected Date
October 22, 2026
EPS Estimate
$2.87
Average shareholder expectationRevenue Estimate
$3.05 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Quest Diagnostics, Inc.
47,000 employees
CEO: Stephen Rusckowski Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy beh...